Lymerix is off the market

April 2002

The Lyme vaccine Lymerix is off the market due to poor sales.

Many factors may have contributed to the low demand. Lymerix is expensive...used in just a few regions...and isn't very effective.

It has also gotten a lot of bad press.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

allow pharmacists to provide emergency contraceptive pills
Diabetes Starlix (nateglinide), a new oral tablet for type 2 diabetes
Diabetes metformin can lower vitamin B12 levels
Diabetes confused about the "sugar-free" candies marketed to patients with diabetes
Men's Health Xatral (ZAY-trall, alfuzosin), a new once-daily drug for benign prostatic hyperplasia
Women's Health new vaginal estrogen tablet called Vagifem
Women's Health latest thinking on treating osteoporosis in postmenopausal women
Infectious Diseases Lymerix is off the market
Cardiology New Canadian hypertension guidelines
Cardiology More patients will be taking Plavix (clopidogrel)
Multiple Sclerosis the different interferons for MS
Obesity & Weight Loss new concerns about the safety of Meridia (sibutramine)
Obesity & Weight Loss natural weight loss products
"nocebo effect"
Alzheimer's Disease link between homocysteine levels and dementia